Challenges of CAR- and TCR-T cell-based therapy for chronic infections
Challenges of CAR- and TCR-T cell-based therapy for chronic infections
复制标题
DOI：
10.1084/jem.20191663
复制
发表时间：
2020-05-01
影响因子：
15.3
通讯作者：
Tan, Anthony Tanoto
中科院分区：
文献类型：
--
作者：
Bertoletti, Antonio;Tan, Anthony Tanoto
While therapy with T cells engineered with a chimeric antigen receptor (CAR) or a classical T cell receptor (TCR) is revolutionizing cancer treatment, its adoption in infectious diseases has been met with considerable resistance. Can we find its value for the cure of infections?
